| Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid (NCT03648996) | University of Missouri-Columbia | 2018-11-01 |
| Community-based Clinical Trial With Microbiota Directed Complementary Foods (MDCFs) Made of Locally Available Food Ingredients for the Management of Children With Post-severe Acute Malnutrition Moderate Acute Malnutrition (Post-SAM MAM) (NCT04015986) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2018-11-01 |
| ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) (NCT03374670) | Ophthotech Corporation | 2018-11-01 |
| Project 2 Airway Potential Hydrogen (pH) in Asthma (NCT03617718) | Case Western Reserve University | 2018-11-01 |
| Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy (NCT03703427) | Zhiyong Yu | 2018-11-01 |
| Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer (NCT03058939) | University of Chicago | 2018-11-01 |
| Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia (NCT04194086) | Zhujiang Hospital | 2018-11-01 |
| Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer (NCT06377722) | Fundacion Oncosur | 2018-11-01 |
| Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars (NCT03580135) | Cairo University | 2018-11-01 |
| Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer (NCT03735082) | Chinese Academy of Medical Sciences | 2018-11-01 |
| Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia (NCT03455517) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2018-10-31 |
| BN Brachyury and Radiation in Chordoma (NCT03595228) | Bavarian Nordic | 2018-10-31 |
| Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT03661307) | M.D. Anderson Cancer Center | 2018-10-31 |
| A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy (NCT03686033) | Eisai Inc. | 2018-10-31 |
| Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer (NCT03672773) | Jonsson Comprehensive Cancer Center | 2018-10-31 |
| A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) (NCT03668119) | Bristol-Myers Squibb | 2018-10-31 |
| Dysport in Post-Surgical Neuralgia (NCT03663101) | Ipsen | 2018-10-30 |
| Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma (NCT03709147) | Marina Garassino | 2018-10-30 |
| Improving Right Ventricular Function in Young Adults Born Preterm (NCT03696758) | University of Wisconsin, Madison | 2018-10-30 |
| QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML (NCT03365661) | Masonic Cancer Center, University of Minnesota | 2018-10-30 |
| Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC (NCT03717155) | Merck KGaA, Darmstadt, Germany | 2018-10-30 |
| Low Dose Aprepitant for Patients Receiving Carboplatin (NCT03237611) | Albert Einstein College of Medicine | 2018-10-30 |
| Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab (NCT03653052) | Simon C Pacey, MD | 2018-10-30 |
| A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells (NCT03718624) | Hebei Medical University | 2018-10-30 |
| Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib (NCT03235245) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-10-30 |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma (NCT03717298) | Catalysis SL | 2018-10-30 |
| Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782) (NCT03664024) | Merck Sharp & Dohme LLC | 2018-10-30 |
| Hydroxyurea and Transfusion (NCT03644953) | Children's National Research Institute | 2018-10-30 |
| An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP (NCT03707353) | University of Oxford | 2018-10-30 |
| Pharmacological Activation of HMN for OSA (NCT03640052) | Brigham and Women's Hospital | 2018-10-30 |
| Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation (NCT03693339) | Asan Medical Center | 2018-10-30 |
| First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) Metastases (NCT03653546) | Alpha Biopharma (Jiangsu) Co., Ltd. | 2018-10-29 |
| Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma (NCT03688451) | Tahir Latif | 2018-10-29 |
| A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) (NCT03656718) | Bristol-Myers Squibb | 2018-10-29 |
| IVIG (Gamunex-C) Treatment Study for POTS Subjects (NCT03919773) | University of Texas Southwestern Medical Center | 2018-10-29 |
| BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis (NCT03648541) | Boehringer Ingelheim | 2018-10-29 |
| A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. (NCT03636347) | Mereo BioPharma | 2018-10-29 |
| Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia (NCT03629171) | M.D. Anderson Cancer Center | 2018-10-29 |
| Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer (NCT03111901) | William Grosh, MD | 2018-10-29 |
| A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE) (NCT03712228) | CSL Behring | 2018-10-29 |
| Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis (NCT03612856) | Aronora, Inc. | 2018-10-29 |
| Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty (NCT03731364) | Concentric Analgesics | 2018-10-29 |
| Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms (NCT04044937) | Thomas Hope | 2018-10-29 |
| An Investigation of Levetiracetam in Alzheimer's Disease (NCT03489044) | University of Oxford | 2018-10-28 |
| Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence (NCT03322267) | National Taiwan University Hospital | 2018-10-27 |
| suPAR to Guide Antibiotics in Emergency Department (NCT03717350) | Hellenic Institute for the Study of Sepsis | 2018-10-27 |
| Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency) (NCT03652259) | Sarepta Therapeutics, Inc. | 2018-10-27 |
| Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation (NCT03721328) | Osteal Therapeutics, Inc. | 2018-10-26 |
| Reducing the Burden of Influenza After Solid-Organ Transplantation (NCT03699839) | Oriol Manuel | 2018-10-26 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) (NCT03558152) | Genentech, Inc. | 2018-10-26 |
| Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer (NCT03601455) | Jonsson Comprehensive Cancer Center | 2018-10-26 |
| Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells (NCT03634501) | Xuanwu Hospital, Beijing | 2018-10-26 |
| Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia (NCT03455504) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2018-10-26 |
| A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer (NCT03721744) | 1Globe Health Institute LLC | 2018-10-25 |
| Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception (NCT03452111) | Premier Research | 2018-10-25 |
| Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT03127215) | National Center for Tumor Diseases, Heidelberg | 2018-10-25 |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897) | Catalysis SL | 2018-10-25 |
| A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors (NCT03601897) | Deciphera Pharmaceuticals, LLC | 2018-10-25 |
| Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT03586609) | M.D. Anderson Cancer Center | 2018-10-25 |
| Non-opioids for Analgesia After Adenotonsillectomy in Children (NCT03618823) | David Chi, MD | 2018-10-25 |
| Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction (NCT03549494) | Catalysis SL | 2018-10-25 |
| Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma (NCT03559543) | Catalysis SL | 2018-10-25 |
| A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS (NCT03059615) | Immune System Key Ltd | 2018-10-25 |
| Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma (NCT03665545) | University Hospital, Geneva | 2018-10-25 |
| Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO) (NCT03472274) | Fundacion CRIS de Investigación para Vencer el Cáncer | 2018-10-25 |
| Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia (NCT03654768) | SWOG Cancer Research Network | 2018-10-24 |
| Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT03580616) | Elijah W. Stommel | 2018-10-24 |
| A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D) (NCT03751007) | Precigen Actobio T1D, LLC | 2018-10-24 |
| Fecal Microbiota Transplantation in Depression (NCT03281044) | Psychiatric Hospital of the University of Basel | 2018-10-24 |
| Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma (NCT03309878) | National Cancer Institute (NCI) | 2018-10-24 |
| Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction? (NCT03963115) | Mahidol University | 2018-10-24 |
| Phase 2 Bunionectomy HTX-011 Administration Study (NCT03718039) | Heron Therapeutics | 2018-10-24 |
| First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome (NCT03594955) | Sanofi | 2018-10-24 |
| Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy (NCT03725761) | University of Wisconsin, Madison | 2018-10-24 |
| Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor (NCT03518138) | Que Oncology | 2018-10-24 |
| Extended Dose Intervals With Oral Cholera Vaccine in Cameroon (NCT03719066) | Johns Hopkins Bloomberg School of Public Health | 2018-10-23 |
| Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)" (NCT03621696) | Washington University School of Medicine | 2018-10-23 |
| Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (NCT03643133) | UNICANCER | 2018-10-23 |
| Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease. (NCT03994393) | University of Sydney | 2018-10-23 |
| Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial (NCT04106024) | Cttq | 2018-10-23 |
| Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M) (NCT03634800) | Weill Medical College of Cornell University | 2018-10-23 |
| Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury (NCT02882373) | M.D. Anderson Cancer Center | 2018-10-23 |
| Fibrinogen Concentrate in Isolated Traumatic Brain Injury (NCT03304899) | Leila Dehghani | 2018-10-23 |
| MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer (NCT03714490) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2018-10-23 |
| Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects (NCT03717272) | Aelis Farma | 2018-10-23 |
| A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection (NCT03369912) | Novartis Pharmaceuticals | 2018-10-23 |
| Albendazole Dose Finding and Pharmacokinetics in Children and Adults (NCT03527745) | Jennifer Keiser | 2018-10-23 |
| Prazosin for Agitation in Alzheimer's Disease (NCT03710642) | Alzheimer's Disease Cooperative Study (ADCS) | 2018-10-23 |
| Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03691714) | Trisha Wise-Draper | 2018-10-23 |
| Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults (NCT03541499) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-10-23 |
| Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis (NCT03688971) | Maruho Co., Ltd. | 2018-10-22 |
| Conditioning SCID Infants Diagnosed Early (NCT03619551) | Center for International Blood and Marrow Transplant Research | 2018-10-22 |
| Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer (NCT03697551) | Ipsen | 2018-10-22 |
| Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma (NCT03732547) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-10-22 |
| Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer (NCT03628066) | NSABP Foundation Inc | 2018-10-22 |
| AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma (NCT03668340) | Dana-Farber Cancer Institute | 2018-10-22 |
| Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects (NCT06473662) | Roger New | 2018-10-22 |
| Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis (NCT03703102) | Kyowa Kirin, Inc. | 2018-10-22 |
| Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies (NCT03539822) | Anwaar Saeed | 2018-10-22 |
| Topical Ionic Contra-Viral Therapy in Actinic Keratosis (NCT03684772) | Maruho Co., Ltd. | 2018-10-22 |